National PH Advocacy Day is coming up on Nov. 13. Little Ella and Kori (mother of Lilly) have created their Still PHighting videos advocating for better research for pulmonary hypertension. Watch their videos and add your voice by making your Still PHighting video today.
PHA is working to ensure that PHA Classroom remains a strong and valuable resource for PH patients, family members and friends. In order to keep providing the PH community with the most relevant information, we need you to tell us what that is. Please take a few minutes to complete this brief survey. Your feedback is extremely valuable to us and will help shape the future of PHA Classroom as well as future PHA programming.
We’d like you to join us for our monthly PHA Patient Telephone Support Group on Oct. 23 at 8 p.m. ET. We provide a safe and caring atmosphere for you to feel supported and empowered by other patients also affected by pulmonary hypertension. In this non-judgmental space you can express your thoughts and concerns freely, develop friendships, share thoughts and learn coping strategies.
Let’s celebrate the importance of words and terms together! We have a glossary of pulmonary hypertension terms and an acronym decoder to help patients and caregivers gain a better understanding of the disease. Knowledge is power!
PHA's public awareness campaign, PHAware, just launched a brand new website, PHAware.org, and a dynamic mobile app! PHAware is our megaphone to bring pulmonary hypertension from rare to everywhere. Join us in using this megaphone to spread PH awareness.
This month is Liver Awareness Month so we would like to share information about pulmonary hypertension caused by advanced liver disease, or portopulmonary hypertension (POPH), a type of pulmonary arterial hypertension (PAH).
Liver disease can cause what is known as “portal hypertension,” meaning increased blood pressure in the veins that enter the liver. This increased pressure causes blood to bypass the liver; as a result, the blood is not subject to the liver’s work, which includes the removal or detoxification of chemicals and poisons in the body.
As a result, the blood vessels of the lung are exposed to possible toxic substances and this can damage the small arteries of the lungs, causing portopulmonary hypertension (POPH), a type of pulmonary arterial hypertension (PAH). This disease has the same characteristic symptoms as those found in cases of PAH that are not associated with liver disease.
Symptoms the patient may notice are similar to those associated with classic PH, and include shortness of breath and limited ability to tolerate exercise.